MEA Non-Invasive Prenatal Testing Market Size is USD 279.5 Million in 2026

MEA Non-Invasive Prenatal Testing Market (By Gestation Period: 0–12 Weeks, 13–24 Weeks, and 25–36 Weeks; By Pregnancy Risk: High and Average Risk and Low Risk; By Method: Cell-free DNA in Maternal Plasma Tests, Biochemical Screening, and Ultrasound Detection; By Technology: NGS, PCR, Array Technology, and Others; By Product: Consumables & Reagents and Instruments; By Application: Trisomy, Microdeletion Syndrome, and Other Applications; By End Use: Hospitals & Clinics and Diagnostic Laboratories) Industry Size, Share, Growth, Trends 2025-2035

Report Code : 1526 | Published : 04 Jun 2026 | Delivery : Immediate | Format : Excel | Author : Aditi Shivarkar, Aman Singh

Revenue,

USD 25 Mn

Forecast Year,

USD 762.71 Mn

CAGR, 2026 - 2035

11.80%

Report Coverage

MEA

Download Databook

The MEA non-invasive prenatal testing market size was estimated at USD 250 million in 2025 and is projected to be worth around USD 762.71 million by 2035, growing at a CAGR of 11.8% from 2026 to 2035. Factors such as increasing awareness of genetic disorders, increasing maternal age, and higher demand for non-invasive methods help to fuel the market's growt

MEA Non-Invasive Prenatal Testing Market Statical Scope

Reports Attributes	Statistics
Market Size in 2025	USD 250 Million
Market Size in 2026	USD 279.5 Million
Market Size by 2035	USD 762.71 Million
CAGR 2026 to 2035	11.8%
Base Year	2025
Forecast Period	2026 to 2035

The Middle East and Africa non-invasive prenatal testing market is also observed to grow due to major technological shifts, such as the adoption of NGS and the use of cell-free DNA tests as a replacement for less accurate screening methods. Growing investments by the government of the region for improved maternal health are also a major market driver.

MEA Non-Invasive Prenatal Testing Market, By Gestation Period, 2025 (%)

Segments	Shares (%)
0–12 Weeks	56%
13–24 Weeks	30%
25–36 Weeks	14%

0-12 Weeks - The dominating segment involves 56% of the market share and is driven by a higher preference for early diagnosis and better clinical decision-making.
13-24 Weeks - The segment holds 30% of the market share as it reflects the mid-pregnancy testing phase, useful for additional screening and confirmation of fetal conditions.

MEA Non-Invasive Prenatal Testing Market, By Pregnancy Risk, 2025 (%)

Segments	Shares (%)
High and Average Risk	68%
Low Risk	32%

High and Average Risk - The dominating segment holds 68% of the market share, driven by higher medical necessity and strong recommendations from healthcare providers.
Low Risk - The segment reflects 32% of the market share as it involves screening for pregnancies without identified risk factors.

MEA Non-Invasive Prenatal Testing Market, By Method, 2025 (%)

Segments	Shares (%)
Cell-free DNA in Maternal Plasma Tests	52%
Biochemical Screening	26%
Ultrasound Detection	22%

Ultrasound Detection - The segment has a notable share of 22% and involves image-based screening methods to identify any fetal abnormalities.
Biochemical Screening - The segment involves 26% of the market share and involves blood-based screening, analyzing biomarkers to assess fetal health risks.

MEA Non-Invasive Prenatal Testing Market, By Technology, 2025 (%)

Segments	Shares (%)
NGS	48%
PCR	22%
Array Technology	20%
Others	10%

NGS - The dominating segment holds 48% of the market share and is driven by its superior accuracy and higher use in prenatal diagnostics.
Array Technology - The segment reflects 20% of the market share and involves a genetic testing method that detects chromosomal variations with the help of microarray platforms.

MEA Non-Invasive Prenatal Testing Market, By Product, 2025 (%)

Segments	Shares (%)
Consumables and Reagents	66%
Instruments	34%

Consumables and Reagents - The dominating segment holds 66% of the market share due to its higher demand and higher testing volume.
Instruments - The segment holds 34% of the market share as they are used for performing and analyzing prenatal tests.

MEA Non-Invasive Prenatal Testing Market, By Application, 2025 (%)

Segments	Shares (%)
Trisomy	58%
Microdeletion Syndrome	20%
Other Applications	22%

Trisomy - The dominating segment holds 58% of the market share and is driven by high prevalence and strong clinical focus on trisomy screening.
Microdeletion Syndrome - The segment has a notable share of 20%, as the segment reflects the detection of small chromosomal deletions causing genetic disorders.

MEA Non-Invasive Prenatal Testing Market, By End Use, 2025 (%)

Segments	Shares (%)
Hospitals and Clinics	62%
Diagnostic Laboratories	38%

Hospitals and Clinics - The segment holds 62% of the market share due to higher patient inflow and integrated diagnostic capabilities.
Diagnostic Laboratories - The segment reflects 38% of the market share, driven by specialized labs conducting advanced prenatal testing and analysis.

Top Companies in the MEA Non-Invasive Prenatal Testing Market

Genesis Genetics (CooperSurgical, Inc.)
Natera, Inc.
Eurofins LifeCodexx GmbH
Illumina, Inc. (Verinata Health, Inc.)
Centogene N.V.
MedGenome Labs Ltd.
Myriad Women's Health, Inc. (Counsyl, Inc.)
F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics)
Qiagen
Laboratory Corp. of America Holdings
Progenity, Inc.
Quest Diagnostics, Inc.

Segments Covered in the Report

By Gestation Period

0–12 Weeks
13–24 Weeks
25–36 Weeks

By Pregnancy Risk

High and Average Risk
Low Risk

By Method

Cell-free DNA in Maternal Plasma Tests
Biochemical Screening
Ultrasound Detection

By Technology

NGS
PCR
Array Technology
Others

By Product

Consumables and Reagents
Instruments

By Application

Trisomy
Microdeletion Syndrome
Other Applications

By End Use

Hospitals and Clinics
Diagnostic Laboratories

List of Tables & Figures

List of Tables

Table 1: MEA Non-Invasive Prenatal Testing Market Size, by Gestation Period, 2025-2035 (USD Billion)
Table 2: MEA Non-Invasive Prenatal Testing Market Size, by Pregnancy Risk, 2025-2035 (USD Billion)
Table 3: MEA Non-Invasive Prenatal Testing Market Size, by Method, 2025-2035 (USD Billion)
Table 4: MEA Non-Invasive Prenatal Testing Market Size, by Technology, 2025-2035 (USD Billion)
Table 5: MEA Non-Invasive Prenatal Testing Market Size, by Product, 2025-2035 (USD Billion)
Table 6: MEA Non-Invasive Prenatal Testing Market Size, by Application, 2025-2035 (USD Billion)
Table 7: MEA Non-Invasive Prenatal Testing Market Size, by End Use, 2025-2035 (USD Billion)
Table 8: MEA Non-Invasive Prenatal Testing Market Size, by 0–12 Weeks, 2025-2035 (USD Billion)
Table 9: MEA Non-Invasive Prenatal Testing Market Size, by 13–24 Weeks, 2025-2035 (USD Billion)
Table 10: MEA Non-Invasive Prenatal Testing Market Size, by 25–36 Weeks, 2025-2035 (USD Billion)
Table 11: MEA Non-Invasive Prenatal Testing Market Size, by High and Average Risk, 2025-2035 (USD Billion)
Table 12: MEA Non-Invasive Prenatal Testing Market Size, by Low Risk, 2025-2035 (USD Billion)
Table 13: MEA Non-Invasive Prenatal Testing Market Size, by Cell-free DNA in Maternal Plasma Tests, 2025-2035 (USD Billion)
Table 14: MEA Non-Invasive Prenatal Testing Market Size, by Biochemical Screening, 2025-2035 (USD Billion)
Table 15: MEA Non-Invasive Prenatal Testing Market Size, by Ultrasound Detection, 2025-2035 (USD Billion)
Table 16: MEA Non-Invasive Prenatal Testing Market Size, by NGS, 2025-2035 (USD Billion)
Table 17: MEA Non-Invasive Prenatal Testing Market Size, by PCR, 2025-2035 (USD Billion)
Table 18: MEA Non-Invasive Prenatal Testing Market Size, by Array Technology, 2025-2035 (USD Billion)
Table 19: MEA Non-Invasive Prenatal Testing Market Size, by Others (Technology), 2025-2035 (USD Billion)
Table 20: MEA Non-Invasive Prenatal Testing Market Size, by Consumables and Reagents, 2025-2035 (USD Billion)
Table 21: MEA Non-Invasive Prenatal Testing Market Size, by Instruments, 2025-2035 (USD Billion)
Table 22: MEA Non-Invasive Prenatal Testing Market Size, by Trisomy, 2025-2035 (USD Billion)
Table 23: MEA Non-Invasive Prenatal Testing Market Size, by Microdeletion Syndrome, 2025-2035 (USD Billion)
Table 24: MEA Non-Invasive Prenatal Testing Market Size, by Other Applications, 2025-2035 (USD Billion)
Table 25: MEA Non-Invasive Prenatal Testing Market Size, by Hospitals and Clinics, 2025-2035 (USD Billion)
Table 26: MEA Non-Invasive Prenatal Testing Market Size, by Diagnostic Laboratories, 2025-2035 (USD Billion)

List of Figures

Figure 1: MEA Non-Invasive Prenatal Testing Market Share, by Gestation Period, 2025 (%)
Figure 2: MEA Non-Invasive Prenatal Testing Market Share, by Pregnancy Risk, 2025 (%)
Figure 3: MEA Non-Invasive Prenatal Testing Market Share, by Method, 2025 (%)
Figure 4: MEA Non-Invasive Prenatal Testing Market Share, by Technology, 2025 (%)
Figure 5: MEA Non-Invasive Prenatal Testing Market Share, by Product, 2025 (%)
Figure 6: MEA Non-Invasive Prenatal Testing Market Share, by Application, 2025 (%)
Figure 7: MEA Non-Invasive Prenatal Testing Market Share, by End Use, 2025 (%)
Figure 8: MEA Non-Invasive Prenatal Testing Market Forecast, 2025-2035 (USD Billion)
Figure 9: 0–12 Weeks Segment Market Forecast, 2025-2035 (USD Billion)
Figure 10: 13–24 Weeks Segment Market Forecast, 2025-2035 (USD Billion)
Figure 11: 25–36 Weeks Segment Market Forecast, 2025-2035 (USD Billion)
Figure 12: High and Average Risk Segment Market Forecast, 2025-2035 (USD Billion)
Figure 13: Low Risk Segment Market Forecast, 2025-2035 (USD Billion)
Figure 14: Cell-free DNA in Maternal Plasma Tests Segment Market Forecast, 2025-2035 (USD Billion)
Figure 15: Biochemical Screening Segment Market Forecast, 2025-2035 (USD Billion)
Figure 16: Ultrasound Detection Segment Market Forecast, 2025-2035 (USD Billion)
Figure 17: NGS Segment Market Forecast, 2025-2035 (USD Billion)
Figure 18: PCR Segment Market Forecast, 2025-2035 (USD Billion)
Figure 19: Array Technology Segment Market Forecast, 2025-2035 (USD Billion)
Figure 20: Others (Technology) Segment Market Forecast, 2025-2035 (USD Billion)
Figure 21: Consumables and Reagents Segment Market Forecast, 2025-2035 (USD Billion)
Figure 22: Instruments Segment Market Forecast, 2025-2035 (USD Billion)
Figure 23: Trisomy Segment Market Forecast, 2025-2035 (USD Billion)
Figure 24: Microdeletion Syndrome Segment Market Forecast, 2025-2035 (USD Billion)
Figure 25: Other Applications Segment Market Forecast, 2025-2035 (USD Billion)
Figure 26: Hospitals and Clinics Segment Market Forecast, 2025-2035 (USD Billion)
Figure 27: Diagnostic Laboratories Segment Market Forecast, 2025-2035 (USD Billion)

Research Methodology

Related Databooks

March 2026